Takeda Pharmaceutical (TAK) files notice to sell 7,889 ADSs on NYSE

Rhea-AI Filing Summary

Takeda Pharmaceutical Company Limited submitted a notice for the proposed sale of American Depositary Shares (ADSs) under Rule 144. The notice covers up to 7,889 ADSs, to be sold through Interactive Brokers LLC on the NYSE on or after July 13, 2026, with an indicated aggregate market value of $132,148.97. It also lists activity in the prior three months, including 25,586 ADSs related to Restricted Stock Unit Awards – Vested dated July 1, 2026, categorized as compensation.

Filing Explained

The July 13 filing identifies 25586 ADSs for sale from vested RSU compensation; it does not establish that the sale occurred.

The July 13, 2026 Form 144 identifies 25586 Takeda ADSs for sale, so the disclosed state is a planned disposition rather than a reported completed sale; it does not disclose an issuer financing or a change to the company’s share structure.

The ADSs are identified as acquired on July 1, 2026 through vested restricted stock unit awards as compensation. No trading plan is disclosed in the supplied filing, so this is a proposed sale with no trading plan disclosed in this filing.

The filing does not provide the filer’s resulting holdings after the proposed sale, so its effect on that holder’s ownership cannot be sized from the supplied evidence.

Sources and calculations

• Takeda Pharmaceutical Company Limited Form 144 (2026-07-13)

Key Figures

ADSs proposed for sale: 7,889 ADSs Aggregate market value: $132,148.97 ADSs sold in past 3 months: 25,586 ADSs +1 more

4 metrics

ADSs proposed for sale 7,889 ADSs American Depositary Shares to be sold on or after July 13, 2026

Aggregate market value $132,148.97 Value associated with 7,889 ADSs proposed for sale

ADSs sold in past 3 months 25,586 ADSs Related to Restricted Stock Unit Awards – Vested on July 1, 2026, categorized as compensation

Planned sale date 07/13/2026 Date associated with proposed ADS sale on NYSE

Key Terms

American Depositary Shares (ADSs), Restricted Stock Unit Awards - Vested, Compensation

3 terms

American Depositary Shares (ADSs) financial

"American Depositary Shares (ADSs) | Interactive Brokers LLC One Pickwick Plaza"

A U.S.-listed certificate that stands for a specific number of shares in a non‑U.S. company held by a U.S. bank, making the foreign stock tradable on American exchanges in dollars. Think of it like a local voucher that represents ownership of an overseas product — it lets U.S. investors buy and sell foreign companies without handling foreign currency or foreign brokerage accounts, but it can affect dividends, voting rights, fees, liquidity and exposure to currency and regulatory differences.

Restricted Stock Unit Awards - Vested financial

"ADSs | 07/01/2026 | Restricted Stock Unit Awards - Vested."

Compensation financial

"25586 | 07/01/2026 | Compensation"

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 07/13/2026 - 06:30 AM Accepted by SEC EDGAR 07/13/2026 - 06:23 AM Learn about SEC filing dates

FAQ

What securities are covered by this Form 144 notice for TAK?

The notice covers American Depositary Shares (ADSs) of Takeda Pharmaceutical Company Limited, with a proposed sale of up to 7,889 ADSs to be executed on the NYSE through Interactive Brokers LLC.

How many Takeda (TAK) ADSs are proposed to be sold and through whom?

The notice states a proposed sale of up to 7,889 ADSs of Takeda Pharmaceutical Company Limited through Interactive Brokers LLC, to be traded on the NYSE on or after July 13, 2026.

What is the reported market value of the Takeda (TAK) ADSs to be sold?

The reported aggregate market value of the 7,889 ADSs proposed for sale is $132,148.97. This amount reflects the valuation associated with the ADSs covered by the Rule 144 notice as of the information provided.

What prior sales are disclosed in the past three months for Takeda (TAK) ADSs?

The notice discloses 25,586 ADSs in the past three months tied to Restricted Stock Unit Awards – Vested dated July 1, 2026, categorized as Compensation in the securities sold during the past three months section.

What is the source of the Takeda (TAK) ADSs listed as prior transactions?

The ADSs listed as prior transactions, totaling 25,586 ADSs, are associated with Restricted Stock Unit Awards – Vested on July 1, 2026, and are shown under the category Compensation for securities sold during the past three months.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
American Depositary Shares (ADSs)	Interactive Brokers LLC One Pickwick Plaza Greenwich CT 06830	7889	132148.97	143310556	07/13/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
ADSs	07/01/2026	Restricted Stock Unit Awards - Vested.	Takeda Pharmaceutical Company Limited			25586	07/01/2026	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)